You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 2, February 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders
 •Bullous Diseases
 •Pemphigus
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Desmoglein ELISAs

A Novel Diagnostic Tool for Pemphigus

Arch Dermatol. 1999;135:195-196.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IMMUNOFLUORESCENCE has long been an objective test for the diagnosis of pemphigus and allied disorders having circulating autoantibodies or having in vivo deposition of immunoglobulins or complements in the lesional skin since the discovery of autoantibodies by Ernst H. Beutner, PhD, and Robert E. Jordon, MD, in the 1960s. However, it was soon noted that immunofluorescence cannot differentiate pemphigus vulgaris (PV) and pemphigus foliaceus (PF) from its staining pattern. Immunoblotting using bovine snout extracts or human epidermal extracts as antigen sources made it possible to differentiate PV and PF by detecting a specific target antigen for each pemphigus, which has a different molecular weight. However, immunoblotting had a limitation because antigens are denatured during immunoblotting procedure and only autoantibodies against sequential or denatured epitopes are detected. This limitation was especially applied to PF antigen.1

The introduction of molecular biology revolutionized this area of dermatology and has allowed us to identify . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Desmoglein 3-ELISA: A Pemphigus Vulgaris–Specific Diagnostic Tool
Petra Lenz, Masayuki Amagai, Beatrix Volc-Platzer, Georg Stingl, and Reinhard Kirnbauer
Arch Dermatol. 1999;135(2):143-148.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.